Journal of Gastrointestinal Oncology

Papers
(The H4-Index of Journal of Gastrointestinal Oncology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i50
Stage cT3 low rectal cancer: analysis of prognostic factors33
The combination of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), interventional hepatoma therapy, targeted therapy, and immunotherapy: a case series of a novel A28
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database27
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study27
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report25
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments24
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment23
Prognostic nomogram for T3–T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis21
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis21
Erratum: Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK21
Impact of new onset diabetes on pancreatic cancer outcomes21
The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma20
Expression and clinical significance of ERBB4 in gastric cancer19
Prognostic and safety analysis of capecitabine monotherapy versus CapeOx (capecitabine plus oxaliplatin) in elderly patients with high-risk stage II and stage III MRD-negative colorectal cancer19
Rectal tumor fragmentation as a response pattern following chemoradiation19
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study19
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study19
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions18
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor18
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study18
Prediction of early recurrence in patients with colorectal liver metastases18
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma18
0.53579998016357